ClinicalTrialsFinder

Giant Cell Arteritis (GCA) Clinical Trials in Boston, Massachusetts

1 recruitingBoston, Massachusetts

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis

Giant Cell Arteritis (GCA)
National Institute of Allergy and Infectious Diseases (NIAID)78 enrolled7 locationsNCT07108387